Αποτελέσματα Αναζήτησης
FIT (Faecal Immunochemical Test) is a test that looks for blood in a sample of your poo. It looks for tiny traces of blood that you might not be able to see and which could be a sign of bowel cancer. The FIT results help your doctor decide whether to refer you urgently for more tests.
- To evaluate the positive predictive value of different cut-off values of FIT for cancer and cancer + high-risk + intermediate-risk adenoma, globally and in each group. - To identify additional independent risk factors for advanced neoplasia.
FIT is a quantitative test - the detection level for haemoglobin detected in a faecal sample is prespecified as to what defines a "positive" or "negative" test. In bowel cancer screening the levels used are significantly higher than if used in symptomatic patients. Efficacy of FIT in detection of colorectal cancer (CRC) over gFOBT (1,2)
12 Ιουν 2018 · Fecal transferrin has been suggested as a complementary or even superior marker for early detection of colorectal cancer (CRC) besides fecal hemoglobin. We aimed to evaluate both markers individually and in combination in a large cohort of participants of screening colonoscopy.
Faecal immunochemical testing (FIT) has a high sensitivity for the detection of colorectal cancer (CRC). In a symptomatic population FIT may identify those patients who require colorectal investigation with the highest priority.
Keeping track of your lab results lets your doctor take action as soon as your blood counts change to help prevent many cancer-related problems and cancer treatment side effects. The two most common types of lab tests are the complete blood count (CBC) and the chemistry panel or metabolic profile.
There are some key differences in how the Faecal Immunochemical Test (FIT) is used to screen asymptomatic people through the bowel cancer screening programmes, and to investigate symptomatic patients. Cancer Research UK have developed infographics to highlight the different uses of FIT.
